Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Longeveron Inc.LGVN · Entity 7608 | Chief Medical Officer | October 01, 2026 | October 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Longeveron Inc.
Report date October 01, 2026 · Filed October 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 68,778 |
Reported balance
After 2026-10-01 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-10-01 · Tax withholding · Disposed 2,913 · Balance 68,778 F1: Shares withheld to satisfy tax obligations in connection with the vesting of a restricted stock unit (RSU) award. F2: Includes RSUs subject to future vesting. F3: Amounts reflect the one-for-ten reverse stock split undertaken by Issuer in August 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares withheld to satisfy tax obligations in connection with the vesting of a restricted stock unit (RSU) award.
F2: Includes RSUs subject to future vesting.
F3: Amounts reflect the one-for-ten reverse stock split undertaken by Issuer in August 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 01, 2026 Filed Oct 5, 2026 22:00 UTC | Longeveron Inc. LGVN · Entity 7608 | Tax withholdingClass A Common Stock | 2,913 | $2.59 | $7,544.67 |
DisclosureSEC source: 0001214659-26-012568 · marketforms-74100.xml · nonDerivative · entry 1 Agafonova Nataliya · CIK 0001985443 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,778 F1 · shares: Shares withheld to satisfy tax obligations in connection with the vesting of a restricted stock unit (RSU) award. F2 · balance_after: Includes RSUs subject to future vesting. F3 · balance_after: Amounts reflect the one-for-ten reverse stock split undertaken by Issuer in August 2026. Read SEC document |
| August 19, 2026 Filed Aug 21, 2026 22:00 UTC | Longeveron Inc. LGVN · Entity 7608 | GrantClass A Common Stock | 286,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-26-010734 · marketforms-73824.xml · nonDerivative · entry 1 Agafonova Nataliya · CIK 0001985443 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 716,914 F1 · shares: Represents the award of time-based vesting Restricted Stock Units (RSUs). F2 · balance_after: Includes RSUs subject to future vesting. Read SEC document |
| July 01, 2026 Filed Jul 7, 2026 00:54 UTC | Longeveron Inc. LGVN · Entity 7608 | Tax withholdingClass A Common Stock | 22,505 | $0.73 | $16,408.40 |
DisclosureSEC source: 0001214659-26-008252 · marketforms-73585.xml · nonDerivative · entry 1 Agafonova Nataliya · CIK 0001985443 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 430,914 F1 · shares: Shares withheld to satisfy tax obligations in connection with the vesting of a restricted stock unit (RSU) award. F2 · balance_after: Includes RSUs subject to future vesting. Read SEC document |
| May 01, 2026 Filed May 5, 2026 22:00 UTC | Longeveron Inc. LGVN · Entity 7608 | GrantClass A Common Stock | 250,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-26-005618 · marketforms-73061.xml · nonDerivative · entry 1 Agafonova Nataliya · CIK 0001985443 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 453,419 F1 · shares: Represents the award of time-based vesting Restricted Stock Units (RSUs). F2 · balance_after: Includes RSUs subject to future vesting. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 21:00 UTC | Longeveron Inc. LGVN · Entity 7608 | Tax withholdingClass A Common Stock | 13,145 | $1.12 | $14,722.40 |
DisclosureSEC source: 0001214659-26-004339 · marketforms-72887.xml · nonDerivative · entry 1 Agafonova Nataliya · CIK 0001985443 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 203,419 F1 · shares: Shares withheld to satisfy tax obligations in connection with the vesting of a restricted stock unit (RSU) award. F2 · balance_after: Includes RSUs subject to future vesting. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 23:00 UTC | Longeveron Inc. LGVN · Entity 7608 | Tax withholdingClass A Common Stock | 10,250 | $0.59 | $6,078.25 |
DisclosureSEC source: 0001214659-26-000206 · marketforms-71778.xml · nonDerivative · entry 1 Agafonova Nataliya · CIK 0001985443 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 216,564 F1 · shares: Shares withheld to satisfy tax obligations in connection with the vesting of a restricted stock unit (RSU) award. F2 · balance_after: Includes RSUs subject to future vesting. Read SEC document |
| October 01, 2025 Filed Oct 3, 2025 22:00 UTC | Longeveron Inc. LGVN · Entity 7608 | Tax withholdingClass A Common Stock | 11,883 | $0.74 | $8,821.94 |
DisclosureSEC source: 0001214659-25-014619 · marketforms-70937.xml · nonDerivative · entry 1 Agafonova Nataliya · CIK 0001985443 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 226,814 F1 · shares: Shares withheld to satisfy the tax obligations in connection with the vesting of a restricted stock unit (RSU) award. F2 · balance_after: Includes RSUs subject to future vesting. Read SEC document |
| July 15, 2025 Filed Jul 17, 2025 23:46 UTC | Longeveron Inc. LGVN · Entity 7608 | GrantStock Option (right to buy) · Derivative | 34,000 | $0.00 Strike: $1.47 | $0.00 |
DisclosureSEC source: 0001214659-25-010575 · marketforms-70106.xml · derivative · entry 2 Agafonova Nataliya · CIK 0001985443 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,000 Underlying: Class A Common Stock · 34,000 shares Expires 2035-07-15 F3 · derivative.exercise_date: The option vests quarterly over a three year period beginning on October 1, 2025. Read SEC document |
| July 15, 2025 Filed Jul 17, 2025 23:46 UTC | Longeveron Inc. LGVN · Entity 7608 | GrantClass A Common Stock | 102,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-25-010575 · marketforms-70106.xml · nonDerivative · entry 1 Agafonova Nataliya · CIK 0001985443 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 238,697 F1 · shares: Represents the award of time-based vesting Restricted Stock Units (RSUs). F2 · balance_after: Includes RSUs subject to future vesting. Read SEC document |
| July 01, 2025 Filed Jul 3, 2025 22:00 UTC | Longeveron Inc. LGVN · Entity 7608 | Tax withholdingClass A Common Stock | 7,431 | $1.28 | $9,511.68 |
DisclosureSEC source: 0001214659-25-010060 · marketforms-70061.xml · nonDerivative · entry 1 Agafonova Nataliya · CIK 0001985443 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 136,697 F1 · shares: Shares withheld to satisfy the tax obligations in connection with the vesting of a restricted stock unit (RSU) award. F2 · balance_after: Includes RSUs subject to future vesting. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 22:00 UTC | Longeveron Inc. LGVN · Entity 7608 | Tax withholdingClass A Common Stock | 7,566 | $1.50 | $11,349.00 |
DisclosureSEC source: 0001214659-25-005400 · marketforms-69103.xml · nonDerivative · entry 1 Agafonova Nataliya · CIK 0001985443 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 144,128 F1 · shares: Shares withheld to satisfy the tax obligations in connection with the vesting of a restricted stock unit award. F2 · balance_after: Includes Restricted Stock Units subject to future vesting. Read SEC document |
| January 02, 2025 Filed Jan 7, 2025 00:15 UTC | Longeveron Inc. LGVN · Entity 7608 | Tax withholdingClass A Common Stock | 6,120 | $1.79 | $10,954.80 |
DisclosureSEC source: 0001214659-25-000231 · marketforms-67760.xml · nonDerivative · entry 1 Agafonova Nataliya · CIK 0001985443 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 151,694 F1 · shares: Shares withheld to satisfy tax obligations in connection with the vesting of a restricted stock unit award. F2 · balance_after: Includes Restricted Stock Units subject to future vesting. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 22:30 UTC | Longeveron Inc. LGVN · Entity 7608 | Tax withholdingClass A Common Stock | 5,316 | $1.88 | $9,994.08 |
DisclosureSEC source: 0001214659-24-017154 · marketforms-67126.xml · nonDerivative · entry 1 Agafonova Nataliya · CIK 0001985443 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 157,814 F1 · shares: Shares withheld to satisfy the tax obligations in connection with the vesting of a restricted stock unit award. F2 · balance_after: Includes Restricted Stock Units subject to future vesting. Read SEC document |
| August 15, 2024 Filed Aug 20, 2024 00:30 UTC | Longeveron Inc. LGVN · Entity 7608 | GrantStock Option (right to buy) · Derivative | 16,250 | $0.00 Strike: $2.46 | $0.00 |
DisclosureSEC source: 0001214659-24-014995 · marketforms-66807.xml · derivative · entry 3 Agafonova Nataliya · CIK 0001985443 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,250 Underlying: Class A Common Stock · 16,250 shares Expires 2034-08-15 F4 · derivative.exercise_date: The option vests quarterly over a three year period beginning on October 1, 2024. Read SEC document |
| August 15, 2024 Filed Aug 20, 2024 00:30 UTC | Longeveron Inc. LGVN · Entity 7608 | Tax withholdingClass A Common Stock | 14,391 | $2.46 | $35,401.86 |
DisclosureSEC source: 0001214659-24-014995 · marketforms-66807.xml · nonDerivative · entry 2 Agafonova Nataliya · CIK 0001985443 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 163,130 F2 · shares: Shares withheld to satisfy the tax obligations in connection with the vesting of an RSU award. F3 · balance_after: Includes RSUs subject to future vesting. Read SEC document |
| August 15, 2024 Filed Aug 20, 2024 00:30 UTC | Longeveron Inc. LGVN · Entity 7608 | GrantClass A Common Stock | 175,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-24-014995 · marketforms-66807.xml · nonDerivative · entry 1 Agafonova Nataliya · CIK 0001985443 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 177,521 F1 · shares: Represents the award of time-based vesting Restricted Stock Units (RSUs). Read SEC document |
| May 02, 2024 Filed May 6, 2024 22:59 UTC | Longeveron Inc. LGVN · Entity 7608 | Tax withholdingClass A Common Stock | 308 | $2.83 | $871.64 |
DisclosureSEC source: 0001214659-24-008444 · marketforms-65770.xml · nonDerivative · entry 1 Agafonova Nataliya · CIK 0001985443 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,771 F1 · balance_after: Amounts reflect the one-for-ten reverse stock split undertaken by Issuer in April 2024. Read SEC document |
| January 02, 2024 Filed Jan 25, 2024 23:00 UTC | Longeveron Inc. LGVN · Entity 7608 | Tax withholdingCommon Stock | 3,074 | $1.32 | $4,057.68 |
DisclosureSEC source: 0001214659-24-001202 · marketforms-64496.xml · nonDerivative · entry 1 Agafonova Nataliya · CIK 0001985443 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,786 F1 · shares: Shares withheld to satisfy the tax obligations in connection with the vesting of a restricted stock unit award. F2 · balance_after: Includes Restricted Stock Units subject to future vesting. Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 21:00 UTC | Longeveron Inc. LGVN · Entity 7608 | Tax withholdingCommon Stock | 3,059 | $2.29 | $7,005.11 |
DisclosureSEC source: 0001214659-23-013142 · marketforms-62768.xml · nonDerivative · entry 1 Agafonova Nataliya · CIK 0001985443 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,860 F1 · shares: Shares withheld to satisfy the tax obligations in connection with the vesting of a restricted stock unit award. F2 · balance_after: Includes 7,500 restricted stock units. Read SEC document |
| August 18, 2023 Filed Aug 22, 2023 21:00 UTC | Longeveron Inc. LGVN · Entity 7608 | Tax withholdingCommon Stock | 3,081 | $3.36 | $10,352.16 |
DisclosureSEC source: 0001214659-23-011606 · marketforms-62280.xml · nonDerivative · entry 1 Agafonova Nataliya · CIK 0001985443 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,919 F1 · shares: Shares withheld to satisfy the tax obligations in connection with the vesting of a restricted stock unit award. F2 · balance_after: Includes 15,000 restricted stock units. Read SEC document |
| July 24, 2023 Filed Aug 2, 2023 21:00 UTC | Longeveron Inc. LGVN · Entity 7608 | GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-23-010670 · marketforms-62164.xml · nonDerivative · entry 1 Agafonova Nataliya · CIK 0001985443 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 F1 · shares: Represents the award of 30,000 Restricted Stock Units, which vest 25% on each of the award date, October 1, 2023, January 1, 2024, and April 1, 2024. F2 · balance_after: Includes 22,500 Restricted Stock Units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.